TY  - BOOK
TI  - A Two-Step Pretargeted Nanotherapy for CD20 Crosslinking May Achieve Superior Anti-Lymphoma Efficacy to Rituximab
PB  - Theranostics
KW  - Medical Technology
KW  - Medtech
UR  - http://www.thno.org/v5i8
ER  -